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Background: Treatment of tuberculosis (TB) in China is partially covered by national programs and health insurance
schemes, though TB patients often face considerable medical expenditures. For some, especially those from poorer
households, non-medical costs, such as transport, accommodation, and nutritional supplementation may be a
substantial additional burden. In this article we aim to evaluate these non-medical costs induced by seeking TB care
using data from a large scale cross-sectional survey.
Methods: A total of 797 TB cases from three cities were randomly selected using a stratified cluster sampling
design. Inpatient medical costs, outpatient medical costs, and direct non-medical costs related to TB treatment
were collected using in-person interviews by trained interviewers. Mean and median non-medical costs for different
sub-groups were calculated and compared using Kruskal-Wallis and Mann–Whitney U tests. Regression analysis was
conducted to assess the influence of different patient characteristics on total non-medical cost.
Results: The median non-medical cost was RMB 1429, with interquartile range RMB 424–2793. The median
non-medical costs relating to inpatient treatment, outpatient treatment, and additional nutrition supplementation
were RMB 540, 91, and 900, respectively. Of the 797 cases, 20 % reported catastrophic expenditure on non-medical
costs. Statistically significant differences were detected between different cities, age groups, geographical locations,
inpatient/outpatient care, education levels and family income groups.
Conclusions: Non-medical costs relating to TB treatment are a serious financial burden for many TB patients. Financial
assistance that can limit this burden is urgently needed during the treatment period, especially for the poor.
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Please see Additional file 1 for translations of the
abstract into the six official working languages of the
United Nations.
Background
China has the second largest burden of tuberculosis
(TB) in the world, accounting for 12 % of all cases [1].
Although China more than halved its TB prevalence rate
from 1990 to 2010 [2], the rate remained high at the end
of this period, at 459 per 100,000 for a population over* Correspondence: tjlq@mail.xjtu.edu.cn
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burdens [3]. Prevalence rates are higher in poor, rural
areas [4] and the poor have less access to TB care and
are less likely to be cured [5]. Substandard living condi-
tions, underlying health problems, malnourishment, a
lack of money to pay for health care and inadequate ac-
cess to health services all play major roles in impeding
the successful treatment of TB [6].
The cost of inpatient treatment of TB in China is
partly funded by health insurance schemes for those
enrolled, and outpatient treatment is funded by China’s
national TB control program [7]. Although out of pocket
(OOP) payments may also be partially reimbursed by
local programs in some areas, patients must meet the
largest share of outpatient care expenditures [8]. Astributed under the terms of the Creative Commons Attribution 4.0 International
by/4.0/), which permits unrestricted use, distribution, and reproduction in any
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relating to treatment was the most cited reason for
default [9], and that non-medical costs constituted a
substantial portion of this burden [10]. Treatment
typically lasts six months and patients make six trips
to their outpatient clinics, potentially incurring travel
and accommodation costs during treatment. While
this is the standard number of visits, a full course of
treatment may be delivered with a minimum of four
visits where patients live a considerable distance from
the facility. These non-medical costs typically include
payments for transport, accommodation, and the cost
of nutritional supplementation during the treatment
period.
Previous international studies have examined the fi-
nancial burden of non-medical costs and their impact
on adherence to treatment. One systematic review of
overall costs for TB patients has shown that non-
medical cost accounted on average for 20 % of total ex-
penditure [11]. Other studies have found that some TB
patients may be discouraged from seeking care or adher-
ing to treatment plans by non-medical costs [12, 13].
Transport and accommodation costs are most often
considered, but one study of hospitalization for TB in
Ghana, Vietnam, and the Dominican Republic indicates
the substantial burden of additional food costs during
treatment [14]. In China, while numerous studies
have investigated the financial burden on TB patients
[15–18], some others have focused on non-medical
costs or the factors that influence them [16, 19], such
as residence location, gender, age, inpatient versus
outpatient care, health insurance status, education
level, family income, and patient category.
Here, a large-scale cross-sectional survey in three
Chinese cities was used to assess the non-medical finan-
cial burden on TB patients relating to expenditures on
transportation, accommodation and supplementary nu-
trition. We also analyzed the factors influencing these
expenditures.
Methods
We designed and conducted a cross-sectional survey
in TB patients. In China, the administrative demarca-
tions move downward from country to provinces to
prefectures/cities to districts/counties and to towns.
The study was undertaken in Zhenjiang City, Jiangsu
Province in eastern China; Yichang City, Hubei Province
in central China; and Hanzhong City, Shaanxi Province in
western China. Sample size calculations indicated that
a minimum of 792 TB cases (264 in each city) were
necessary as the assumed sample proportion of cata-
strophic expenditure on non-medical costs were 20 %,
with 5 % as half the width of the confidence interval,
and α = 0.05. In each city one county/district wasrandomly selected by a random number from each
category of those with high, middle and low GDP per
capita. Three townships/streets were then selected at
random in each selected county/district and thirty TB
cases were randomly selected from each township/
street using a list of registered cases. Patients who
completed normal treatment or stopped treatment
during 2012 were included in the study. We excluded
patients with communication barriers, such as those
with hearing impairments. We also excluded patients
with serious diseases and migrant workers who did
not join the survey within the study period. Patients
with mental illnesses were excluded as well. In total,
797 TB patients were recruited and informed consent
of each participant was obtained.
Interviews were conducted by trained enumerators
using a structured questionnaire to collect the medical
and non-medical costs (transportation, accommodation,
and nutritional supplementation) of TB treatment. Infor-
mation regarding personal demographic and socio-
economic status (age, sex, education, family income/
expenditure, etc.; Table 1), reimbursements from health
insurance, and financial assistance from government agen-
cies was also collected. The field survey was conducted
between April 2013 and May 2013.
Only patients with a ‘confirmed’ TB diagnoses were in-
cluded. Most had at least one sputum smear test and
one chest x-ray. Indirect expenditures on transport and
accommodation incurred by patients, their families and
others related to seeking and accessing TB treatment
during pre-diagnostic, diagnostic and post-diagnostic pe-
riods, as well as during hospitalization where applicable,
were recalled by patients and their caregivers,. The cost
for nutritional supplementation during TB treatment
was estimated by extracting the cost of extra food ex-
penditure (such as meat, milk, vitamins, etc.). We
attempted to minimize the recall bias via in-depth inter-
views with the patient.
Ethical approval was sought and granted for this re-
search by the Ethical Committee of China CDC. It was
recognized that the right and the welfare of the subject
were adequately protected; the potential risks were out-
weighed by the potential benefits. The ethical approval
number was 201307.
Statistical analysis
We quantified non-medical costs by aggregating the
transport, accommodation, and nutritional supplementa-
tion expenditures related to TB health care. Overall, 752
patients reported complete non-medical costs for trans-
port, accommodation, and nutritional supplementation,
while others missed some portion of the above. Cases
with missing data were deleted when analyzing the
corresponding costs. Mean and median non-medical
Table 1 Basic characteristics of TB patients according to study site a
Characteristic Hanzhong Yichang Zhenjiang Total
Age in year, (Mean ± SDb, years) 55.8 ± 14.4 53.6 ± 15.0 59.3 ±14.7 56.2 ±14.9
Sex Male 211 (78.1) 191 (72.3) 192 (73.0) 594 (74.5)
Female 59 (21.9) 73 (27.7) 71 (27.0) 203 (25.5)
Family size, (Mean ± SD, people) 3.1 ± 1.4 3.0 ± 1.4 3.4 ±1.7 3.2 ±1.5
Area Rural 252 (93.3) 249 (94.3) 235 (89.4) 736 (92.3)
Urban 18 (6.7) 15 (5.7) 28 (10.6) 61 (7.7)
Patient category New patient 218 (80.7) 227 (86.0) 193 (73.4) 638 (80.1)
Relapse patient 43 (15.9) 37 (14.0) 68 (25.9) 148 (18.6)
Failure of previously untreated patient 5 (1.9) 0 (0.0) 2 (0.8) 7 (0.9)
Failure of re-treated patient /chronic 4 (1.5) 0 (0.0) 0 (0.0) 4 (0.5)
Education Never attended school 75 (27.8) 30 (11.4) 58 (22.1) 163 (20.5)
Primary school 85 (31.5) 91 (34.5) 86 (32.7) 262 (32.9)
Junior high school or at the same level 89 (33.0) 96 (36.4) 84 (31.9) 269 (33.8)
High school or at the same level 21 (7.8) 47 (17.8) 35 (13.3) 103 (12.9)
Health insurance With health insurance 267 (98.9) 260 (98.5) 257 (97.7) 784 (98.4)
Without health insurance 3 (1.1) 4 (1.5) 6 (2.3) 13 (1.6)
Family income, (Median (P25–P75b), RMB 1000c) 15.0 (5.0–30.0) 20.0 (9.2–32.6) 36.0 (13.0–63.6) 21.4 (7.6–40.0)
Family expenditure, (Median (P25–P75b), RMB 1000c) 15.0 (7.5–23.5) 20.0 (9.0–30.0) 20.0 (10.0–35.0) 20.0 (9.8–30.0)
aData are n(%) unless otherwise indicated. TB: tuberculosis
bSD: standard deviation. P25: 25th percentile. P75: 75th percentile
cRMB 1000: a currency exchange rate of Chinese RMB 628 Yuan to US$100 Yuan at the end of 2012,RMB1000 = US$159
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groups using Mann–Whitney U and Kruskal-Wallis
tests and a 5 % significance level. Linear regression
was then used to model the relationships between
non-medical costs and the explanatory variables avail-
able from the survey data. We also separated the
transport plus accommodation costs and the add-
itional nutrition cost for the multi-variate analysis. All
the statistical analysis was done using the SAS version
9.3 statistical software package (SAS Institute Inc.,
Cary, North Carolina).
We considered the following patient variables to be
potentially correlated with non-medical costs as they
were major risk factors for the non-medical cost:
residence location (the three study cities), gender, age
(<65 years or > =65 years), residence type (urban or
rural), inpatient care (with or without), health insur-
ance (covered or uncovered), education level (never
attended school, primary school, junior high school,
high school or higher), family income (as a propor-
tion of the median in each city), and patient category
(new or relapse patient).
Results
Table 1 shows the basic demographic characteristics of
the participants. In total, 797 TB patients were includedin the study, with mean ages ranging from 53.6 to 59.3
across the three study sites. Some 74.5 % were male, and
80.1 % were new patients. Most came from rural areas,
and their degree of education was limited. Overall one-
fifth (almost 28 % in Hanzhong) had no formal educa-
tion. Only 12.9 % of the participants had received a high
school education or similar. The average family income
was RMB 21,400 (equaling to US$3408, a currency ex-
change rate of Chinese RMB 628 Yuan to US$100 at the
end of 2012), ranging from RMB 15,000 (US$2389) in
Hanzhong to RMB 36,000 (US$5732) in Zhenjiang. It
was notable that the average family expenditure (RMB
20,000) was almost equal to the average income, indi-
cating that many families would have very limited
ability to save. As expected, given the government
promotion of the urban and rural health insurance
schemes, almost all patients were covered by one of
these schemes. The largest percentage (41.9 %) of
participants made six trips to their outpatient clinic
during treatment, potentially incurring travel and ac-
commodation costs.
As shown in Table 2, non-medical financial costs re-
lated to TB treatment varied considerably across study
sites. The overall mean and median expenditure was
considerably lower in Yichang than in Hanzhong and
Zhenjiang. However, this was a simply reflection of the
Table 2 Non-medical financial cost related to TB treatment by study site (RMBa)
n Hanzhong Yichang Zhenjiang Total
Mean Median P25-P75b Mean Median P25-P75 Mean Median P25-P75 Mean Median P25-P75
Total 752c 2308 1785 853-3185 1453 968 318-1880 2061 1800 381-3000 1943 1429 424-2793
Inpatient 371
Travel fee 130 30 10-100 257 50 20-270 124 15 0-100 158 30 6-120
Accommodation fee 822 530 150-1060 1018 760 300-1350 547 315 108-630 766 500 150-1000
Subtotal 958 600 210-1240 1285 815 350-1710 673 400 200-823 928 540 208-1200
Outpatient 753
Travel fee 98 60 24-120 150 120 40-204 77 28 0-96 109 60 12-140
Accommodation fee 124 30 0-100 56 20 0-75 20 0 0-0 68 0 0-60
Subtotal 223 91 30-240 206 144 60-270 97 36 0-120 176 91 20-210
Additional nutrition fee 770 1586 1200 300-2400 828 435 0-1200 1596 1200 0-2400 1337 900 0-1800
aRMB 1000: a currency exchange rate of Chinese RMB 628 Yuan to US$100 Yuan at the end of 2012, RMB1000 = US$159
bP25: 25th percentile. P75: 75th percentile
cThe total non-medical cost is the sum of the inpatient cost, outpatient cost and the additional nutrition fee. The total number of patients is less than that in the
subgroup because of missing data
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tion – around half that in the other cities. Both travel
and accommodation costs were substantially higher in
Yichang, which was probably a reflection of the in-
creased distance that patients had to travel to a desig-
nated TB facility.
Table 3 reveals the non-medical economic burden of
TB care, as measured by the numbers/proportions of pa-
tients with catastrophic health care expenditure on care.
Overall, some 20 % of all respondents reported that their
non-medical costs exceeded 40 % of their non-food ex-
penditure, while 37 % reported that these costs exceeded
10 % of their annual household income. The non-
medical burden was highest in Hanzhong using both
measures.
Table 4 shows the influence of different patient charac-
teristics on total non-medical costs. In addition to the
variation between the study cities, the relationshipsTable 3 Description of the non-medical burden of TB health care, n
Non-medical cost in TB health care Hanzhong Y
≥ 40 % of the annual capacity to pay 65 (26.9) 2
≥ 10 % of the annual household income 132 (52.4) 8
Groups of non-medical cost (RMB)
≤ 200 35 (13.8) 4
201 ~ 1000 45 (17.7) 8
1001 ~ 2000 64 (25.2) 6
2001 ~ 4000 66 (26.0) 3
4001 ~ 6000 29 (11.4) 1
≥ 6001 15 (5.9) 6
a Chi-square test was used to compare the difference of percentage between studybetween non-medical costs and age group, residence
type (urban/rural), receiving inpatient care, education
and family income were statistically significant.
The results of the regression analysis are reported
in Table 5. In this analysis we combined transporta-
tion and accommodation costs as both are related to
geographic factors such as distance from home to fa-
cility and availability of transportation options. The
table indicates that after controlling for other vari-
ables, living in Yichang was still associated with
higher transportation and accommodation costs and
lower additional nutrition costs. For transportation
and accommodation costs specifically, only care type
and age were likely to have a significant influence in
addition to city of residence. However, additional nu-
trition costs were also positively correlated with
higher education level, family income and urban
residence.(%)
ichang Zhenjiang Total P_value a
9 (11.9) 51 (21.2) 145 (20.0) <0.011
1 (32.7) 62 (25.3) 275 (36.9) <0.011
5 (18.1) 53 (21.3) 133 (17.7) <0.011
2 (32.9) 31 (12.4) 158 (21.0)
4 (25.7) 60 (24.1) 188 (25.0)
8 (15.3) 70 (28.1) 174 (23.1)
4 (5.6) 26 (10.4) 69 (9.2)
(2.4) 9 (3.6) 30 (4.0)
sites
Table 4 Comparison of non-medical cost of TB care between
different characteristics, RMB









< 65 years 2163 1605











Never attended school 1389 1040
Primary school 1864 1268
Junior high school 2146 1658
High school or higher 2479 1837
Family income <0.001
Lower half 1560 1066
Higher half 2298 1700
Category 0.540
New patient 1884 1406
Relapse patient 2182 1600
a P_value was calculated by univariate analysis
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China’s national TB control program requires patients to
visit the TB outpatient clinic every month for six months
or at least four times during the first, second, fifth and
last month of the treatment regimen [20]. A majority of
participants in this study adhered to this requirement,
although many of them suffered from heavy financial
burden caused by TB treatment. In many cases, espe-
cially where patients lived in more remote areas – which
were typically associated with lower household incomes –
this entailed considerable expenditure on travel and
accommodation, leading to non-medical expenditures that
may be comparable to out-of-pocket payments for
hospitalization.Non-medical costs of TB treatment placed a consider-
able financial burden on patients. Some 25 % of partici-
pants spent RMB 1001 ~ 2000 on non-medical costs
while over 23 % spent RMB 2001 ~ 4000. These costs
were considerable when compared to household expen-
ditures, which ranged from RMB 15,000 to 20,000 across
the three cities, and to incomes, which ranged from
RMB 15,000 to 36,000.
Inpatient care was positively associated with both
types of costs (P < 0.05), which can be explained by
the fact that receiving inpatient care increased the ac-
commodation costs for patients and their compan-
ions, and the likelihood of purchasing additional food
during hospitalization. The negative impacts of higher
age on both cost components may be ascribed to
older people’s limited ability to travel to health facil-
ities (especially for patients in remote areas) and to
their lower willingness and capacity to pay for add-
itional food. This is consistent with results from pre-
vious studies which revealed that older people do not
want use their children’s money for treatment as they
believe the money could be used for more meaningful
purposes, for example, the education of their grand-
children [16, 21].
The impact of other patient characteristics on non-
medical costs were mixed for the two types of costs.
Geographic constraints played a major role in the influ-
ence of location on costs, as Yichang and Hanzhong
have vast mountainous areas, which increases travel
costs and adds to the difficulty of purchasing additional
food. Indicators of socio-economic status – residence
type, education and family income – were all positively
associated with additional nutrition costs but had no sig-
nificant influence on travel and accommodation costs.
This would suggest that patients with higher levels of
education, a greater ability to pay and wider availability
of nutritional supplements (in urban areas) were more
willing and able to consume more nutritious foods to
help with recovery.
The results of the regression analyses revealed the dif-
ferent nature of the two types of non-medical costs, and
suggested how to reduce patient costs in following the
prescribed treatment regimen. Future policies might best
serve to focus on reducing travel and accommodation
costs, which have the greatest impact on poorer house-
holds in remote areas. One study has confirmed the role
of transportation subsidies in reducing the financial bur-
den of TB patients but suggests that the amount pro-
vided needs to be more substantial [19, 22]. Our study
indicates that geographic factors exert such a major in-
fluence on non-medical costs that the amount of travel
subsidy should be determined by location of residence.
Additional subsidies may also be appropriate to encour-
age adherence to treatment by older patients. For the
Table 5 Regression analysis of total non-medical cost and patient characteristics a
Variable Total non-medical cost Transportation plus accommodation cost Additional nutrition cost
Parameter SE P value Parameter SE P value Parameter SE P value
Location
Hanzhong 8.00 1.86 <.0001 −1.98 1.19 0.0970 13.31 2.02 <.0001
Yichang Ref
Zhenjiang 4.45 1.86 0.0167 −6.42 1.19 <.0001 10.87 2.02 <.0001
Sex Ref: male 2.66 1.73 0.1241 0.40 1.11 0.7203 2.31 1.89 0.2209
age Ref: aged <65 −6.12 1.70 0.0003 −2.38 1.08 0.0285 −5.24 1.84 0.0046
Residence type Ref: rural 10.18 2.82 0.0003 −0.62 1.83 0.7356 11.35 3.05 0.0002
Inpatient care Ref: without 14.86 1.50 <.0001 18.53 0.96 <.0001 4.00 1.62 0.0140
Health insurance Ref: covered 7.12 5.91 0.2290 6.88 3.84 0.0737 1.86 6.22 0.7657
Education
Never attended school Ref
Primary school 6.22 2.15 0.0040 0.31 1.37 0.8197 6.47 2.33 0.0057
Junior high school 7.32 2.24 0.0011 1.36 1.43 0.3432 6.49 2.44 0.0079
High school or higher 9.19 2.90 0.0016 0.27 1.84 0.8815 9.25 3.15 0.0034
Family income Ref: lower half 4.12 1.57 0.0090 0.45 1.00 0.6517 6.16 1.70 0.0003
Category Ref: new patients 1.61 1.87 0.3891 −1.54 1.19 0.1983 2.69 2.02 0.1838
a Following variables were enrolled in the regression medel: residence location (the three study cities), gender, age (<65 years or > =65 years), residence type
(urban or rural), inpatient care (with or without), health insurance (covered or uncovered), education level (never attended school, primary school, Junior high
school, high school or higher), family income (as a proportion of the median in each city), and patient category (new or relapse patient)
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previous study which indicated higher non-medical costs
for those not covered by any health insurance [16].
This study is not without its limitations. Firstly, inves-
tigators were trained to extract information as reliably as
possible. However, the recall bias of annual income and
non-direct medical costs can hardly be avoided due to
the long treatment duration. Patients’ estimation of
transportation, accommodation and additional food
costs may not be accurate. Secondly, some patients re-
ceived therapy mainly in 2011 and so major non-medical
costs were incurred in 2011; however, these patients re-
ported their 2012 income which may not have reflected
their economic statuses during treatment when incomes
may have been reduced. In addition, only three cities
form eastern China, central China and western China
were selected by location instead of by TB burden level.
Cities with the highest TB burden, such as Tibet,
Xinjiang and Guizhou, were not involved. Thus, the
present results were limited when considering TB bur-
den levels. Future studies on the economic burden of
non-medical costs could gather more accurate informa-
tion through timely monitoring during treatment in
broader areas.
Conclusion
Non-medical costs related to TB treatment imposed a
considerable financial burden for TB patients, oftenaccounting for a considerable proportion of their annual
income. Geographic factors played such an important
role in transportation and accommodation costs that
transportation subsidies should be provided based on
the patients’ places of residence.
Additional file
Additional file 1: Multilingual abstracts in the six official working
languages of the United Nations. (PDF 542 kb)
Abbreviations
GDP: Gross Domestic Product; OOP: Out-of-Pocket payment; TB: Tuberculosis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
QL developed the study concepts, analyzed the data, and prepared the
manuscript. He had full access to all the data of the study and was
responsible for the integrity of the data and the accuracy of the data
analysis. WJ, QW, YS, JG, KDS and QL participated in the field study,
interpreted and commented on the manuscript. HL participated in the
interpretation of findings and paper editing. All authors read and approved
the final manuscript.
Acknowledgments
The study upon which this paper was written is part of the large program
entitled “China National Health and Family Planning Commission and the
Gates Foundation TB Project” - a collaboration between the Government of
China and the Bill and Melinda Gates Foundation (Grant No. 51914), and
implemented by the China Center of Disease Control and Prevention (CDC).
The Duke Global Health Institute, USA/Duke Kunshan University in China,
Li et al. Infectious Diseases of Poverty  (2016) 5:5 Page 7 of 7and Nanjing Medical University, Huazhong University of Science and
Technology and Xi’an Jiaotong University in China were contracted by the
Foundation and China CDC to undertake the baseline survey, and monitoring
and evaluation of innovative financial models of TB/MDRTB control and care in
China. The authors are also grateful for the supports and valuable comments
provided by Prof. Shenglan Tang, Duke Global Health Institute.
Author details
1Department of Biostatistics and Epidemiology, School of Public Health, Xi’an
Jiaotong University, Xi’an, Shaanxi, China. 2Global Health Research Center,
Duke Kunshan University, Kunshan, Jiangsu, China. 3Duke Global Health
Institute, Duke University, Durham, NC, USA. 4Institute of Development
Studies at the University of Sussex, Brighton, UK.
Received: 24 August 2015 Accepted: 26 December 2015References
1. WHO. Global tuberculosis report 2014. Geneva: World Health
Organization; 2014.
2. Wei X, Zou G, Walley J, Yin J, Lonnroth K, Uplekar M, et al. China tuberculosis
policy at crucial crossroads: comparing the practice of different hospital and
tuberculosis control collaboration models using survey data. PLoS One.
2014;9(3):e90596. doi:10.1371/journal.pone.0090596.
3. Technical Guidance Group of the Fifth National TB Epidemiological Survey,
The Office of the Fifth National TB Epidemiological Survey. The fifth
national tuberculosis epidemiological survey in 2010. Chin J Antituberc.
2012;34(8):485–508.
4. WHO. Global tuberculosis control: epidemiology, strategy, financing. Geneva:
World Health Organization; 2009.
5. World Health Organization. Tackling poverty in tuberculosis control. Lancet.
2005;366(9503):2063. doi:10.1016/S0140-6736(05)67862-2.
6. Yao H, Wei X, Liu J, Zhao J, Hu D, Walley JD. Evaluating the effects of
providing financial incentives to tuberculosis patients and health providers
in China. Int J Tuberc Lung Dis. 2008;12(10):1166–72.
7. Li W, Li X, Zhang H, Li R, Cheng J, Wang L. Investigation on the current
health insurance status of pulmonary tuberculosis cases without drug
resistance in certain areas of China. Chin Prev Med (in Chinese).
2012;13(6):401–5.
8. Liu Q, Smith H, Wang Y, Tang S, Wang Q, Garner P. Tuberculosis patient
expenditure on drugs and tests in subsidised, public services in China: a
descriptive study. Trop Med Int Health. 2010;15(1):26–32. doi:10.1111/j.1365-
3156.2009.02427.x.
9. Long Q, Smith H, Zhang T, Tang S, Garner P. Patient medical costs for
tuberculosis treatment and impact on adherence in China: a systematic
review. BMC Public Health. 2011;11:393. doi:10.1186/1471-2458-11-393.
10. Liu X, Thomson R, Gong Y, Zhao F, Squire SB, Tolhurst R, et al. How
affordable are tuberculosis diagnosis and treatment in rural China? An
analysis from community and tuberculosis patient perspectives. Trop Med
Int Health. 2007;12(12):1464–71. doi:10.1111/j.1365-3156.2007.01953.x.
11. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden
for tuberculosis patients in low-and middle-income countries: a systematic
review. Eur Respir J. 2014;43(6):1763–75. doi:10.1183/09031936.00193413.
12. Chen C, Liu J, Yao H. Economic and geographic factor analysis for cases
with limited access to health service in Hubei FIDELIS area. Chin J Anti-
Tuberculosis. 2007;29(4):293–7.
13. Shargie EB, Lindtjorn B. Determinants of treatment adherence among
smear-positive pulmonary tuberculosis patients in Southern Ethiopia.
PLoS Med. 2007;4(2):e37. doi:10.1371/journal.pmed.0040037.
14. Nhung NV, Bonsu F, Suarez P, Gyapong M, Hoa NB, Awini E, et al. Free
tuberculosis diagnosis and treatment are not enough: patient cost evidence
from three continents. Int J Tuberc Lung Dis. 2013;17(3):381–7. doi:10.5588/
ijtld.12.0368.
15. Chen S, Zhong J, Wang X. Investigation and analysis of tuberculosis
pulmonary diseases in Zhejiang Province. Chin J of PHM (in Chinese).
2014;30(2):147–9.
16. Zhang M, Wu W, Tong Y, Yang X, Huang W, Wu H. Family financial burden
of patients with tuberculosis in Guizhou. China Prev Med (in Chinese). 2014;
15(2):114–7.17. Li Q, Cao X, Zhao G, Zhang L, Xu L. Analysis on economic burden of disease
and its influencing factors of pulmonary tuberculosis patient in Shangdong
Province. Chin Health Econ (in Chinese). 2010;29(4):71–3.
18. Wang Q, Wang L, Li R, Ruan Y, Chen M, Sun Q. Analysis of the medical
expenses and economic burden of pulmonary tuberculosis patients in three
cities.
Chin J Antituberc (in Chinese). 2013;35(4):240–5.
19. Kun S, Lixia W, Daiyu H, Qiuyang C, Yongming L, Ying L, et al. A qualitative
study of transport subsidy project on enabling poor TB patients to complete
the treatment course. Chin Health Resour (in Chinese). 2010;13(6):280–3.
20. MOH. China Tuberculosis Prevention and Control Plan: guideline for
programme implementation. Beijing, China: Disease Control Department
[in Chinese]; 2002.
21. Xu B, Fochsen G, Xiu Y, Thorson A, Kemp JR, Jiang QW. Perceptions and
experiences of health care seeking and access to TB care–a qualitative
study in rural Jiangsu Province. China Health Policy. 2004;69(2):139–49.
doi:10.1016/j.healthpol.2003.11.006.
22. Zhao Q, Wang LX, Tao T, Xu B. Impacts of the “transport subsidy initiative
on poor TB patients” in rural China: a patient-cohort based longitudinal
study in rural China. PLoS One. 2013;8(11):e82503. doi:10.1371/journal.
pone.0082503.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
